Russia to soon register second Covid-19 vaccine, says Vladimir Putin

Putin also complimented the country's ability to counter the pathogen adding that the healthcare system is "now ready to efficiently counter' Covid-19

Coronavirus, vaccine, covid, drugs, Sepsivac, clinical trials
In August, Russia became the first country in the world to register a vaccine against Covid-19.
ANI Others
2 min read Last Updated : Sep 23 2020 | 7:46 PM IST

Russia will soon register a second vaccine against COVID-19, informed President Vladimir Putin on Wednesday.

"By the way, the second vaccine against coronavirus will be registered soon," as reported by Sputnik quoting Putin while speaking to the Russian Upper House lawmakers.

On Tuesday, national consumer health watchdog said that another vaccine -- developed by the Vector research centre and dubbed as EpiVacCorona would be registered by October 15.

Putin also complimented the country's ability to counter the pathogen adding that the healthcare system is "now ready to efficiently counter' COVID-19.

"During the pandemic, we have perceived the value of every human life, the value of the heroic effort of healthcare workers, and of course, the enormous role that healthcare system's efficiency plays for the society and the country. Over the past months, its capabilities have increased significantly. The healthcare system is now ready to efficiently counter the coronavirus infection and the seasonal surge in cold-related diseases," Putin added.

In August, Russia became the first country in the world to register a vaccine against COVID-19.

As per the latest updates by Johns Hopkins University, Russia is fourth on the list with regard to most COVID-19 cases in the world -- after the US, India and Brazil -- with 1,117,487 cases and 19,720 deaths due to the pathogen.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusVladimir PutinCoronavirus Vaccine

First Published: Sep 23 2020 | 7:37 PM IST

Next Story